2003•PubMedRequires access

Onychomycosis in children: an overview.

Aditya Kumar Gupta, Alayne R. Skinner, Robert Baran

Abstract

Onychomycosis in children is relatively uncommon, with a prevalence of approximately 0.3% worldwide. The most common etiologic organism in Trichophyton rubrum. The oral antifungal agents terbinafine, itraconazole, and fluconazole, and the topical nail lacquers ciclopirox and amorolfine, are not approved for use in treating onychomycosis in children. However, these agents appear to be effective and safe in this indication.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 21 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Medicine, Terbinafine, Itraconazole, Trichophyton rubrum, Dermatology, Fluconazole, Antifungal, Nail (fastener)